Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should Coronavirus Vaccine Investors Worry About The Cold Chain?


Fool.com's Healthcare and Cannabis Bureau Chief Corinne Cardina interviewed Richard Horton on Motley Fool Live on Oct. 9. Horton runs the British medical journal The Lancet and has been at the forefront of publishing data about the coronavirus pandemic this year. He also recently published a book called The COVID-19 Catastrophe.

Here, Horton explains why investors should know about the "cold chain" when it comes to distributing mRNA vaccines like those being developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX), as well as by Moderna (NASDAQ: MRNA).

 

Continue reading


Source Fool.com

Like: 0
PFE
Share

Comments